Drug Safety

Guest: Dr. Merrie Mosedale, Assistant Director, Institute for Drug Safety Sciences; Research Assistant Professor, Department of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, UNC-Chapel Hill
Topics: Drug safety, genetics of adverse drug reactions, drug-induced liver injury, translational pharmacogenomics

 

Dr. Merrie Mosedale

 

UNC Institute for Drug Safety Sciences

Merrie’s UNC Eshelman faculty page

“The Benefits of a Mouse Population-based Approach”

“Mosedale receives Sternfel Prize”

“Mosedale Awarded Regulatory Science Award from Burroughs Wellcome Fund”

Click to Download: Radio In Vivo November 28, 2018

Advertisements

GeneCentric Therapeutics, Inc.

Guest: Dr. Myla Lai-Goldman, Co-founder, CEO & President, GeneCentric Therapeutics, Inc., Research Triangle Park, NC
Topics: Dr. Lai-Goldman’s career in science, medicine, and business; pathology; GeneCentric Therapeutics’ Cancer Subtype Platform, precision medicine, cancer drug development

 

Dr. Myla Lai-Goldman

 

GeneCentric Therapeutics, Inc.

GeneCentric’s management team

Hatteras Venture Partners

LabCorp

Click to Download: Radio In Vivo November 1, 2017

Pharmacogenetic Testing

Guest: Jivan Moaddeb, Pharm.D., clinical pharmacist, Center for Applied Genomics & Precision Medicine, Duke University School of Medicine
Topics: Pharmacogenetic testing, clinical implementation of pharmacogenomics, patient adherence, medication therapy management

moaddebphoto2

Dr. Jivan Moaddeb

 

The Haga Group (Dr. Susanne Haga, Dr. Jivan Moaddeb) home page

Publications authored by Jivan Moaddeb

Pharmacogenetic testing: current evidence of clinical utility

The potential impact of pharmacogenetic testing on medication adherence

Click to Download: Radio In Vivo July 1, 2015